7-Day Antibiotic Regimen Non-Inferior to 14-Day for Uncomplicated Neonatal Sepsis in RCT

Photo by Mika Baumeister / Unsplash

European journal of pediatrics Published April 16, 2026 Medically reviewed April 25, 2026 Study authors: Jain Ayushie, Agarwal Nikita, Anand Rohit, Padhi Phalguni, Jindal Atul PubMed ↗ DOI ↗ By Dr. Sofia Müller, MD · Lifespan & Whole-Person Care

Key Takeaway

Note that 7-day antibiotic therapy is non-inferior to 14-day therapy for uncomplicated neonatal sepsis.

This randomized control assessor-blinded trial investigated antibiotic duration in 140 babies randomized to 70 in each arm. The population included neonates weighing ≥ 1000 g with culture-positive sepsis, excluding those with CNS infections, septic arthritis, and life-threatening congenital malformations. The study was conducted in a tertiary Neonatal Intensive Care Unit in Central India. Follow-up occurred at 48 h post-antibiotic treatment and weekly for 35 days. Researchers aimed to determine optimal treatment length. This design allowed for blinded assessment of outcomes. Randomization ensured balanced groups for comparison.

The intervention involved 7-day antibiotic therapy compared against 14-day antibiotic therapy. The primary outcome was relapse of sepsis. Results showed low incidence in both groups, establishing non-inferiority. Secondary outcomes included hospital stay and respiratory support, both shorter or less in 7-day group with p < 0.05. Fatalities and definitive relapses were none recorded. No deaths occurred during the study period. Statistical significance favored the shorter course for resource utilization metrics. Resource utilization improved with the shorter duration.

Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported. Limitations note that data is lacking-especially from Central India. Practice relevance suggests a 7-day antibiotic regimen for uncomplicated neonatal sepsis is not inferior to a 14-day regimen. Clinicians should consider these findings alongside the absence of reported safety metrics and regional limitations. Generalizability may be constrained by the specific geographic setting and lack of safety reporting. Further research is needed to confirm safety profiles. Caution is advised due to missing safety data.

Study Details

Study typeRct

EvidenceLevel 2

PublishedApr 2026

PMID41984236

View Original Abstract ↓

UNLABELLED: The trial aimed to establish the non-inferiority of a 7-day antibiotic therapy for uncomplicated neonatal sepsis when compared to the standard 14-day therapy. This study was a parallel-group, randomized non-inferiority assessor-blinded trial conducted in a tertiary Neonatal Intensive Care Unit in Central India. Neonates weighing ≥ 1000 g with suspected sepsis were screened and those meeting criteria were enrolled. Exclusions included babies with CNS (central nervous system) infections, septic arthritis, and life-threatening congenital malformations. Participants were observed for 7 days on antibiotics and re-evaluated; those with positive blood cultures were then randomized to receive either 7 or 14 days of antibiotics. The primary outcome was the relapse of sepsis, and a sample size of 70 in each arm was calculated based on a non-inferiority margin. Follow-ups were conducted for 48 h post-antibiotic treatment and weekly for 35 days to monitor any recurrence of illness. During the study, 917 babies with suspected sepsis were admitted, of which 256 had culture-positive sepsis. After excluding those with meningitis, staphylococcus, and fungal infections, 140 babies showed improvement at day 5 and were randomized into two groups: one receiving antibiotics for 7 days and the other for 14 days, each consisting of 70 babies. Klebsiella pneumoniae was the prevalent organism. The 7-day group had a shorter hospital stay (p < 0.05) and less respiratory support (p < 0.05). Outcomes revealed a low incidence of probable relapse in both groups, with no fatalities or definitive relapses recorded. CONCLUSIONS: A 7-day antibiotic regimen for uncomplicated neonatal sepsis is not inferior to a 14-day regimen. WHAT IS KNOWN: • Unregulated use of antibiotics can lead to a myriad of problems, especially in neonates. • There is some evidence that uncomplicated neonatal sepsis can be treated with short-course antibiotics. WHAT IS NEW: • Data is lacking-especially from Central India. • This trial checks if it is possible to reduce the duration of antibiotic therapy in uncomplicated neonatal sepsis.

7-Day Antibiotic Regimen Non-Inferior to 14-Day for Uncomplicated Neonatal Sepsis in RCT

Study Details

Standardized formal resuscitation training likely reduces neonatal mortality in low- and middle-income countries compared to no training or basic training.

A Simple Training Program Is Saving Newborn Lives in Poor Countries

Clinical research that matters. Delivered to your inbox.

7-Day Antibiotic Regimen Non-Inferior to 14-Day for Uncomplicated Neonatal Sepsis in RCT

Study Details

Standardized formal resuscitation training likely reduces neonatal mortality in low- and middle-income countries compared to no training or basic training.

A Simple Training Program Is Saving Newborn Lives in Poor Countries

Clinical research that matters. Delivered to your inbox.

Related in Pediatrics

From Other Specialties